$3.88
-0.02-0.60%
At close: -
$3.77
-0.11-2.75%
After Hours: Nov 25, 4:05 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Knight Therapeutics in recent months.
Browse guidance and forecast on all stocks.